Snapshot from Aug 25, 2026 at 07:00 UTC. For live data and tracking: View Live
Tech medical research

Supercentenarians show high CD4 CTL levels

Analysis based on 6 articles · First reported Aug 19, 2026 · Last updated Aug 25, 2026

Sentiment
20
Attention
1
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The findings could spur interest in longevity and immunology research, potentially benefiting biotech companies focused on age-related diseases. However, the study is early-stage and based on a small sample, so market impact is limited.

Biotechnology Healthcare

A study published in Cell Reports on August 19 found that supercentenarians (people aged 110+) have unusually high levels of CD4 cytotoxic T lymphocytes (CD4 CTLs), a rare type of immune cell that can kill tumor cells. Researchers led by Kosuke Hashimoto of the University of Osaka analyzed blood samples from 28 Japanese adults. The median proportion of CD4 CTLs rose from 4% in people aged 70-99 to 9.6% in centenarians and 17.6% in supercentenarians. The cells showed signs of clonal expansion, with the largest clone averaging 33.3% of CD4 CTLs. Receptor sequences matched those found in cancer patients, suggesting a possible link to cancer surveillance. The study does not prove that CD4 CTLs cause longevity but suggests the immune system may continue adapting in extreme old age. The research was supported by several Japanese institutions.

per
Lead researcher who conducted the study and provided key insights.
Importance 100.0 Sentiment 20.0
priv
Publisher of the journal Cell Reports; disseminated the findings.
Importance 80.0 Sentiment 10.0
cnt
Country where the study participants were from; relevant to national health research.
Importance 50.0 Sentiment 10.0
oth
University involved in research projects; provided funding.
Importance 30.0 Sentiment 5.0
ngo
Funding body that supported the research through KAKENHI grants.
Importance 30.0 Sentiment 5.0
govactor
Government ministry that provided a research grant.
Importance 30.0 Sentiment 5.0
ngo
Foundation that provided funding for the research.
Importance 20.0 Sentiment 5.0
ngo
Foundation that provided funding for the research.
Importance 20.0 Sentiment 5.0
oth
Institute that provided funding through a promotion program.
Importance 20.0 Sentiment 5.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.